𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines

✍ Scribed by Aki Takeuchi; Shuichi Kaneko; Eiki Matsushita; Takeshi Urabe; Atsushi Shimoda; Kenichi Kobayashi

Book ID
106181113
Publisher
Springer Japan
Year
1999
Tongue
English
Weight
176 KB
Volume
34
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Modulation of cisplatin sensitivity and
Modulation of cisplatin sensitivity and accumulation by interferon Ξ±-2A in human squamous carcinoma cell lines
✍ Vicram Gupta; Jitesh P. Jani; Erling O. Emerson; Bing H. Xu; Domenic Scalamogna; πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 593 KB

## Abstract This study was undertaken to elucidate the mechanism(s) of potentiation of cisplatin (CDDP) cytotoxicity by interferon α‐2a (IFN α‐2a) in human squamous carcinoma cell lines SCC‐25 and SCC‐4. IFN α‐2a treatment significantly increased the cytotoxicity of CDDP in both cell lines in a dos

Natural interferon-alpha activity in hor
Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines
✍ Fortunata Iacopino; Gioacchino Robustelli della Cuna; Gigliola Sica πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 209 KB πŸ‘ 1 views

This study explored the activity of natural interferon-alpha (nIFN-a) in regulating cell growth of 6 breast-cancer cell lines. The anti-proliferative effect of the combination nIFN-a and tamoxifen (TAM) or medroxyprogesterone acetate (MPA) in CG-5 estrogen-sensitive mammary cancer cells was investig

Altered adhesion properties and alpha v
Altered adhesion properties and alpha v integrin expression in a cisplatin-resistant human ovarian carcinoma cell line
✍ Sylvie Maubant; SΓ©verine Cruet-Hennequart; Laurent Poulain; Franck Carreiras; Fr πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 416 KB

## Abstract In order to elucidate the mechanisms underlying the development of chemoresistance in ovarian cancer, we have previously established the IGROV1‐R10 cisplatin‐resistant cell line by mimicking a clinical protocol of drug administration on IGROV1 human ovarian carcinoma cells. Both IGROV1

Mechanism of cross-resistance to cisplat
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line
✍ Shivendra V. Singh; Bing H. Xu; Jitesh P. Jani; Erling O. Emerson; Mary G. Backe πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 730 KB

This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr